Clinical and demographic characteristics of study participants
| Study site | SUN | MRC | UCRC | KPS | UNAM | Total |
|---|---|---|---|---|---|---|
| Participants (n) | 161 | 209 | 171 | 117 | 49 | 707 |
| Age, mean±SD, years | 37.4±11.3 | 34.9±12.1 | 33.1±10 | 39.9±13.6 | 36.5±9.6 | 36.0±11.8 |
| Men, n (%) | 68 (42) | 123 (59) | 87 (51) | 59 (50) | 28 (57) | 365 (52) |
| HIV pos, n (%) | 28 (17) | 20 (10) | 28 (16) | 67 (57) | 27 (55) | 170 (24) |
| QFT pos, n (%) | 105 (69) | 83 (41) | 119 (70) | 44 (38) | 35 (71) | 386 (56) |
| Definite TB, n (%) | 22 (14) | 53 (25) | 59 (35) | 18 (15) | 33 (67) | 185 (26) |
| Probable TB, n (%) | 4 (2) | 13 (6) | 4 (2) | 3 (3) | 5 (10) | 29 (4) |
| Total TB*, (n) | 26 | 66 | 63 | 21 | 38 | 214 |
| No-PTB, n (%) | 133 (83) | 140 (67) | 108 (63) | 96 (82) | 10 (20) | 487 (69) |
| Questionable, n (%) | 2 (1) | 3 (1) | 0 (0) | 0 (0) | 1 (2) | 6 (1) |
The number and characteristics of participants enrolled from the different study sites are shown.
*Total TB cases=all the Definite TB+Probable TB cases.
KPS, Karonga Prevention Study, Malawi; MRC, Medical Research Council Unit, The Gambia; No-PTB, non-‘pulmonary TB’; pos, positive; QFT, Quantiferon TB Gold In Tube; SUN, Stellenbosch University, South Africa; TB, pulmonary TB; UCRC, Makerere University, Uganda; UNAM, University of Namibia, Namibia.